Global Hadron Therapy Market Growth 2018-2023
The report requires updating with new data and is sent in 48 hours after order is placed.
Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
Over the next five years, LPI(LP Information) projects that Hadron Therapy will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Hadron Therapy market for 2018-2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Hadron Therapy market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Research objectives
Radiation therapy is the medical use of ionizing radiation to treat cancer. In conventional radiation therapy, beams of X rays (high energy photons) are produced by accelerated electrons and then delivered to the patient to destroy tumour cells. Using crossing beams from many angles, radiation oncologists irradiate the tumour target while trying to spare the surrounding normal tissues. Inevitably some radiation dose is always deposited in the healthy tissues.
When the irradiating beams are made of charged particles (protons and other ions, such as carbon), radiation therapy is called hadrontherapy. The strength of hadrontherapy lies in the unique physical and radiobiological properties of these particles; they can penetrate the tissues with little diffusion and deposit the maximum energy just before stopping. This allows a precise definition of the specific region to be irradiated. The peaked shape of the hadron energy deposition is called Bragg peak and has become the symbol of hadrontherapy. With the use of hadrons the tumour can be irradiated while the damage to healthy tissues is less than with X-rays.
The idea of using protons for cancer treatment was first proposed in 1946 by the physicist Robert Wilson, who later became the founder and first director of the Fermi National Accelerator Laboratory (Fermilab) near Chicago. The first patients were treated in the 1950s in nuclear physics research facilities by means of non-dedicated accelerators. Initially, the clinical applications were limited to few parts of the body, as accelerators were not powerful enough to allow protons to penetrate deep in the tissues.
In the late 1970s improvements in accelerator technology, coupled with advances in medical imaging and computing, made proton therapy a viable option for routine medical applications. However, it has only been since the beginning of the 1990s that proton facilities have been established in clinical settings, the first one being in Loma Linda, USA. Currrently about thirty proton centres are either in operation or in construction worldwide.
Over the next five years, LPI(LP Information) projects that Hadron Therapy will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Hadron Therapy market for 2018-2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Hadron Therapy market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
- Electron Beam
- Proton Beam
- Neutron Beam
- Carbon Ion Beam
- Alpha Particle Beam
- Beta Particle Beam
- Pediatric Cancer
- Bone and Soft Tissue Cancer
- Prostate Cancer
- Lung Cancer
- Liver Cancer
- Eye Cancer
- Head & Neck Cancer
- Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Spain
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Koninklijke Philips N.V.
- Advanced Oncotherapy
- Varian Medical Systems, Inc.
- Optivus Proton Therapy, Inc.
- Hitachi, Ltd.
- Mevion Medical Systems
- ProTom International
- Mitsubishi Electric Corporation
- Sumitomo Corporation
- ProNova Solutions, LLC
Research objectives
- To study and analyze the global Hadron Therapy consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
- To understand the structure of Hadron Therapy market by identifying its various subsegments.
- Focuses on the key global Hadron Therapy manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
- To analyze the Hadron Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.
- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
- To project the consumption of Hadron Therapy submarkets, with respect to key regions (along with their respective key countries).
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hadron Therapy Consumption 2013-2023
2.1.2 Hadron Therapy Consumption CAGR by Region
2.2 Hadron Therapy Segment by Type
2.2.1 Electron Beam
2.2.2 Proton Beam
2.2.3 Neutron Beam
2.2.4 Carbon Ion Beam
2.2.5 Alpha Particle Beam
2.2.6 Beta Particle Beam
2.3 Hadron Therapy Consumption by Type
2.3.1 Global Hadron Therapy Consumption Market Share by Type (2013-2018)
2.3.2 Global Hadron Therapy Revenue and Market Share by Type (2013-2018)
2.3.3 Global Hadron Therapy Sale Price by Type (2013-2018)
2.4 Hadron Therapy Segment by Application
2.4.1 Pediatric Cancer
2.4.2 Bone and Soft Tissue Cancer
2.4.3 Prostate Cancer
2.4.4 Lung Cancer
2.4.5 Liver Cancer
2.4.6 Eye Cancer
2.4.7 Head & Neck Cancer
2.4.8 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
2.5 Hadron Therapy Consumption by Application
2.5.1 Global Hadron Therapy Consumption Market Share by Application (2013-2018)
2.5.2 Global Hadron Therapy Value and Market Share by Application (2013-2018)
2.5.3 Global Hadron Therapy Sale Price by Application (2013-2018)
3 GLOBAL HADRON THERAPY BY PLAYERS
3.1 Global Hadron Therapy Sales Market Share by Players
3.1.1 Global Hadron Therapy Sales by Players (2016-2018)
3.1.2 Global Hadron Therapy Sales Market Share by Players (2016-2018)
3.2 Global Hadron Therapy Revenue Market Share by Players
3.2.1 Global Hadron Therapy Revenue by Players (2016-2018)
3.2.2 Global Hadron Therapy Revenue Market Share by Players (2016-2018)
3.3 Global Hadron Therapy Sale Price by Players
3.4 Global Hadron Therapy Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Hadron Therapy Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Hadron Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 HADRON THERAPY BY REGIONS
4.1 Hadron Therapy by Regions
4.1.1 Global Hadron Therapy Consumption by Regions
4.1.2 Global Hadron Therapy Value by Regions
4.2 Americas Hadron Therapy Consumption Growth
4.3 APAC Hadron Therapy Consumption Growth
4.4 Europe Hadron Therapy Consumption Growth
4.5 Middle East & Africa Hadron Therapy Consumption Growth
5 AMERICAS
5.1 Americas Hadron Therapy Consumption by Countries
5.1.1 Americas Hadron Therapy Consumption by Countries (2013-2018)
5.1.2 Americas Hadron Therapy Value by Countries (2013-2018)
5.2 Americas Hadron Therapy Consumption by Type
5.3 Americas Hadron Therapy Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hadron Therapy Consumption by Countries
6.1.1 APAC Hadron Therapy Consumption by Countries (2013-2018)
6.1.2 APAC Hadron Therapy Value by Countries (2013-2018)
6.2 APAC Hadron Therapy Consumption by Type
6.3 APAC Hadron Therapy Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Hadron Therapy by Countries
7.1.1 Europe Hadron Therapy Consumption by Countries (2013-2018)
7.1.2 Europe Hadron Therapy Value by Countries (2013-2018)
7.2 Europe Hadron Therapy Consumption by Type
7.3 Europe Hadron Therapy Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hadron Therapy by Countries
8.1.1 Middle East & Africa Hadron Therapy Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Hadron Therapy Value by Countries (2013-2018)
8.2 Middle East & Africa Hadron Therapy Consumption by Type
8.3 Middle East & Africa Hadron Therapy Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Hadron Therapy Distributors
10.3 Hadron Therapy Customer
11 GLOBAL HADRON THERAPY MARKET FORECAST
11.1 Global Hadron Therapy Consumption Forecast (2018-2023)
11.2 Global Hadron Therapy Forecast by Regions
11.2.1 Global Hadron Therapy Forecast by Regions (2018-2023)
11.2.2 Global Hadron Therapy Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hadron Therapy Forecast by Type
11.8 Global Hadron Therapy Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Koninklijke Philips N.V.
12.1.1 Company Details
12.1.2 Hadron Therapy Product Offered
12.1.3 Koninklijke Philips N.V. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Koninklijke Philips N.V. News
12.2 Advanced Oncotherapy
12.2.1 Company Details
12.2.2 Hadron Therapy Product Offered
12.2.3 Advanced Oncotherapy Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Advanced Oncotherapy News
12.3 Varian Medical Systems, Inc.
12.3.1 Company Details
12.3.2 Hadron Therapy Product Offered
12.3.3 Varian Medical Systems, Inc. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Varian Medical Systems, Inc. News
12.4 Optivus Proton Therapy, Inc.
12.4.1 Company Details
12.4.2 Hadron Therapy Product Offered
12.4.3 Optivus Proton Therapy, Inc. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Optivus Proton Therapy, Inc. News
12.5 Hitachi, Ltd.
12.5.1 Company Details
12.5.2 Hadron Therapy Product Offered
12.5.3 Hitachi, Ltd. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Hitachi, Ltd. News
12.6 Mevion Medical Systems
12.6.1 Company Details
12.6.2 Hadron Therapy Product Offered
12.6.3 Mevion Medical Systems Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Mevion Medical Systems News
12.7 ProTom International
12.7.1 Company Details
12.7.2 Hadron Therapy Product Offered
12.7.3 ProTom International Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 ProTom International News
12.8 Mitsubishi Electric Corporation
12.8.1 Company Details
12.8.2 Hadron Therapy Product Offered
12.8.3 Mitsubishi Electric Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Mitsubishi Electric Corporation News
12.9 Sumitomo Corporation
12.9.1 Company Details
12.9.2 Hadron Therapy Product Offered
12.9.3 Sumitomo Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Sumitomo Corporation News
12.10 ProNova Solutions, LLC
12.10.1 Company Details
12.10.2 Hadron Therapy Product Offered
12.10.3 ProNova Solutions, LLC Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 ProNova Solutions, LLC News
13 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hadron Therapy Consumption 2013-2023
2.1.2 Hadron Therapy Consumption CAGR by Region
2.2 Hadron Therapy Segment by Type
2.2.1 Electron Beam
2.2.2 Proton Beam
2.2.3 Neutron Beam
2.2.4 Carbon Ion Beam
2.2.5 Alpha Particle Beam
2.2.6 Beta Particle Beam
2.3 Hadron Therapy Consumption by Type
2.3.1 Global Hadron Therapy Consumption Market Share by Type (2013-2018)
2.3.2 Global Hadron Therapy Revenue and Market Share by Type (2013-2018)
2.3.3 Global Hadron Therapy Sale Price by Type (2013-2018)
2.4 Hadron Therapy Segment by Application
2.4.1 Pediatric Cancer
2.4.2 Bone and Soft Tissue Cancer
2.4.3 Prostate Cancer
2.4.4 Lung Cancer
2.4.5 Liver Cancer
2.4.6 Eye Cancer
2.4.7 Head & Neck Cancer
2.4.8 Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
2.5 Hadron Therapy Consumption by Application
2.5.1 Global Hadron Therapy Consumption Market Share by Application (2013-2018)
2.5.2 Global Hadron Therapy Value and Market Share by Application (2013-2018)
2.5.3 Global Hadron Therapy Sale Price by Application (2013-2018)
3 GLOBAL HADRON THERAPY BY PLAYERS
3.1 Global Hadron Therapy Sales Market Share by Players
3.1.1 Global Hadron Therapy Sales by Players (2016-2018)
3.1.2 Global Hadron Therapy Sales Market Share by Players (2016-2018)
3.2 Global Hadron Therapy Revenue Market Share by Players
3.2.1 Global Hadron Therapy Revenue by Players (2016-2018)
3.2.2 Global Hadron Therapy Revenue Market Share by Players (2016-2018)
3.3 Global Hadron Therapy Sale Price by Players
3.4 Global Hadron Therapy Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Hadron Therapy Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Hadron Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 HADRON THERAPY BY REGIONS
4.1 Hadron Therapy by Regions
4.1.1 Global Hadron Therapy Consumption by Regions
4.1.2 Global Hadron Therapy Value by Regions
4.2 Americas Hadron Therapy Consumption Growth
4.3 APAC Hadron Therapy Consumption Growth
4.4 Europe Hadron Therapy Consumption Growth
4.5 Middle East & Africa Hadron Therapy Consumption Growth
5 AMERICAS
5.1 Americas Hadron Therapy Consumption by Countries
5.1.1 Americas Hadron Therapy Consumption by Countries (2013-2018)
5.1.2 Americas Hadron Therapy Value by Countries (2013-2018)
5.2 Americas Hadron Therapy Consumption by Type
5.3 Americas Hadron Therapy Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hadron Therapy Consumption by Countries
6.1.1 APAC Hadron Therapy Consumption by Countries (2013-2018)
6.1.2 APAC Hadron Therapy Value by Countries (2013-2018)
6.2 APAC Hadron Therapy Consumption by Type
6.3 APAC Hadron Therapy Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 EUROPE
7.1 Europe Hadron Therapy by Countries
7.1.1 Europe Hadron Therapy Consumption by Countries (2013-2018)
7.1.2 Europe Hadron Therapy Value by Countries (2013-2018)
7.2 Europe Hadron Therapy Consumption by Type
7.3 Europe Hadron Therapy Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hadron Therapy by Countries
8.1.1 Middle East & Africa Hadron Therapy Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Hadron Therapy Value by Countries (2013-2018)
8.2 Middle East & Africa Hadron Therapy Consumption by Type
8.3 Middle East & Africa Hadron Therapy Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 MARKETING, DISTRIBUTORS AND CUSTOMER
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Hadron Therapy Distributors
10.3 Hadron Therapy Customer
11 GLOBAL HADRON THERAPY MARKET FORECAST
11.1 Global Hadron Therapy Consumption Forecast (2018-2023)
11.2 Global Hadron Therapy Forecast by Regions
11.2.1 Global Hadron Therapy Forecast by Regions (2018-2023)
11.2.2 Global Hadron Therapy Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hadron Therapy Forecast by Type
11.8 Global Hadron Therapy Forecast by Application
12 KEY PLAYERS ANALYSIS
12.1 Koninklijke Philips N.V.
12.1.1 Company Details
12.1.2 Hadron Therapy Product Offered
12.1.3 Koninklijke Philips N.V. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Koninklijke Philips N.V. News
12.2 Advanced Oncotherapy
12.2.1 Company Details
12.2.2 Hadron Therapy Product Offered
12.2.3 Advanced Oncotherapy Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Advanced Oncotherapy News
12.3 Varian Medical Systems, Inc.
12.3.1 Company Details
12.3.2 Hadron Therapy Product Offered
12.3.3 Varian Medical Systems, Inc. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Varian Medical Systems, Inc. News
12.4 Optivus Proton Therapy, Inc.
12.4.1 Company Details
12.4.2 Hadron Therapy Product Offered
12.4.3 Optivus Proton Therapy, Inc. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Optivus Proton Therapy, Inc. News
12.5 Hitachi, Ltd.
12.5.1 Company Details
12.5.2 Hadron Therapy Product Offered
12.5.3 Hitachi, Ltd. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Hitachi, Ltd. News
12.6 Mevion Medical Systems
12.6.1 Company Details
12.6.2 Hadron Therapy Product Offered
12.6.3 Mevion Medical Systems Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Mevion Medical Systems News
12.7 ProTom International
12.7.1 Company Details
12.7.2 Hadron Therapy Product Offered
12.7.3 ProTom International Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 ProTom International News
12.8 Mitsubishi Electric Corporation
12.8.1 Company Details
12.8.2 Hadron Therapy Product Offered
12.8.3 Mitsubishi Electric Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Mitsubishi Electric Corporation News
12.9 Sumitomo Corporation
12.9.1 Company Details
12.9.2 Hadron Therapy Product Offered
12.9.3 Sumitomo Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Sumitomo Corporation News
12.10 ProNova Solutions, LLC
12.10.1 Company Details
12.10.2 Hadron Therapy Product Offered
12.10.3 ProNova Solutions, LLC Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 ProNova Solutions, LLC News
13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES
Figure Picture of Hadron Therapy
Table Product Specifications of Hadron Therapy
Figure Hadron Therapy Report Years Considered
Figure Market Research Methodology
Figure Global Hadron Therapy Consumption Growth Rate 2013-2023 (K Units)
Figure Global Hadron Therapy Value Growth Rate 2013-2023 ($ Millions)
Table Hadron Therapy Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Electron Beam
Table Major Players of Electron Beam
Figure Product Picture of Proton Beam
Table Major Players of Proton Beam
Figure Product Picture of Neutron Beam
Table Major Players of Neutron Beam
Figure Product Picture of Carbon Ion Beam
Table Major Players of Carbon Ion Beam
Figure Product Picture of Alpha Particle Beam
Table Major Players of Alpha Particle Beam
Figure Product Picture of Beta Particle Beam
Table Major Players of Beta Particle Beam
Table Global Consumption Sales by Type (2013-2018)
Table Global Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure Global Hadron Therapy Consumption Market Share by Type (2013-2018)
Table Global Hadron Therapy Revenue by Type (2013-2018) ($ million)
Table Global Hadron Therapy Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Hadron Therapy Value Market Share by Type (2013-2018)
Table Global Hadron Therapy Sale Price by Type (2013-2018)
Figure Hadron Therapy Consumed in Pediatric Cancer
Figure Global Hadron Therapy Market: Pediatric Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Pediatric Cancer (2013-2018) ($ Millions)
Figure Global Pediatric Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Bone and Soft Tissue Cancer
Figure Global Hadron Therapy Market: Bone and Soft Tissue Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Bone and Soft Tissue Cancer (2013-2018) ($ Millions)
Figure Global Bone and Soft Tissue Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Prostate Cancer
Figure Global Hadron Therapy Market: Prostate Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Prostate Cancer (2013-2018) ($ Millions)
Figure Global Prostate Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Lung Cancer
Figure Global Hadron Therapy Market: Lung Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Lung Cancer (2013-2018) ($ Millions)
Figure Global Lung Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Liver Cancer
Figure Global Hadron Therapy Market: Liver Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Liver Cancer (2013-2018) ($ Millions)
Figure Global Liver Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Eye Cancer
Figure Hadron Therapy Consumed in Head & Neck Cancer
Figure Hadron Therapy Consumed in Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
Table Global Consumption Sales by Application (2013-2018)
Table Global Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure Global Hadron Therapy Consumption Market Share by Application (2013-2018)
Table Global Hadron Therapy Value by Application (2013-2018)
Table Global Hadron Therapy Value Market Share by Application (2013-2018)
Figure Global Hadron Therapy Value Market Share by Application (2013-2018)
Table Global Hadron Therapy Sale Price by Application (2013-2018)
Table Global Hadron Therapy Sales by Players (2016-2018) (K Units)
Table Global Hadron Therapy Sales Market Share by Players (2016-2018)
Figure Global Hadron Therapy Sales Market Share by Players in 2016
Figure Global Hadron Therapy Sales Market Share by Players in 2017
Table Global Hadron Therapy Revenue by Players (2016-2018) ($ Millions)
Table Global Hadron Therapy Revenue Market Share by Players (2016-2018)
Figure Global Hadron Therapy Revenue Market Share by Players in 2016
Figure Global Hadron Therapy Revenue Market Share by Players in 2017
Table Global Hadron Therapy Sale Price by Players (2016-2018)
Figure Global Hadron Therapy Sale Price by Players in 2017
Table Global Hadron Therapy Manufacturing Base Distribution and Sales Area by Players
Table Players Hadron Therapy Products Offered
Table Hadron Therapy Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Hadron Therapy Consumption by Regions 2013-2018 (K Units)
Table Global Hadron Therapy Consumption Market Share by Regions 2013-2018
Figure Global Hadron Therapy Consumption Market Share by Regions 2013-2018
Table Global Hadron Therapy Value by Regions 2013-2018 ($ Millions)
Table Global Hadron Therapy Value Market Share by Regions 2013-2018
Figure Global Hadron Therapy Value Market Share by Regions 2013-2018
Figure Americas Hadron Therapy Consumption 2013-2018 (K Units)
Figure Americas Hadron Therapy Value 2013-2018 ($ Millions)
Figure APAC Hadron Therapy Consumption 2013-2018 (K Units)
Figure APAC Hadron Therapy Value 2013-2018 ($ Millions)
Figure Europe Hadron Therapy Consumption 2013-2018 (K Units)
Figure Europe Hadron Therapy Value 2013-2018 ($ Millions)
Figure Middle East & Africa Hadron Therapy Consumption 2013-2018 (K Units)
Figure Middle East & Africa Hadron Therapy Value 2013-2018 ($ Millions)
Table Americas Hadron Therapy Consumption by Countries (2013-2018) (K Units)
Table Americas Hadron Therapy Consumption Market Share by Countries (2013-2018)
Figure Americas Hadron Therapy Consumption Market Share by Countries in 2017
Table Americas Hadron Therapy Value by Countries (2013-2018) ($ Millions)
Table Americas Hadron Therapy Value Market Share by Countries (2013-2018)
Figure Americas Hadron Therapy Value Market Share by Countries in 2017
Table Americas Hadron Therapy Consumption by Type (2013-2018) (K Units)
Table Americas Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure Americas Hadron Therapy Consumption Market Share by Type in 2017
Table Americas Hadron Therapy Consumption by Application (2013-2018) (K Units)
Table Americas Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure Americas Hadron Therapy Consumption Market Share by Application in 2017
Figure United States Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure United States Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Canada Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Canada Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Mexico Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Mexico Hadron Therapy Value Growth 2013-2018 ($ Millions)
Table APAC Hadron Therapy Consumption by Countries (2013-2018) (K Units)
Table APAC Hadron Therapy Consumption Market Share by Countries (2013-2018)
Figure APAC Hadron Therapy Consumption Market Share by Countries in 2017
Table APAC Hadron Therapy Value by Countries (2013-2018) ($ Millions)
Table APAC Hadron Therapy Value Market Share by Countries (2013-2018)
Figure APAC Hadron Therapy Value Market Share by Countries in 2017
Table APAC Hadron Therapy Consumption by Type (2013-2018) (K Units)
Table APAC Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure APAC Hadron Therapy Consumption Market Share by Type in 2017
Table APAC Hadron Therapy Consumption by Application (2013-2018) (K Units)
Table APAC Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure APAC Hadron Therapy Consumption Market Share by Application in 2017
Figure China Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure China Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Japan Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Japan Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Korea Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Korea Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure India Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure India Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Australia Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Australia Hadron Therapy Value Growth 2013-2018 ($ Millions)
Table Europe Hadron Therapy Consumption by Countries (2013-2018) (K Units)
Table Europe Hadron Therapy Consumption Market Share by Countries (2013-2018)
Figure Europe Hadron Therapy Consumption Market Share by Countries in 2017
Table Europe Hadron Therapy Value by Countries (2013-2018) ($ Millions)
Table Europe Hadron Therapy Value Market Share by Countries (2013-2018)
Figure Europe Hadron Therapy Value Market Share by Countries in 2017
Table Europe Hadron Therapy Consumption by Type (2013-2018) (K Units)
Table Europe Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure Europe Hadron Therapy Consumption Market Share by Type in 2017
Table Europe Hadron Therapy Consumption by Application (2013-2018) (K Units)
Table Europe Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure Europe Hadron Therapy Consumption Market Share by Application in 2017
Figure Germany Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Germany Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure France Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure France Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure UK Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure UK Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Italy Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Italy Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Russia Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Russia Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Spain Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Spain Hadron Therapy Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Hadron Therapy Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Hadron Therapy Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Hadron Therapy Consumption Market Share by Countries in 2017
Table Middle East & Africa Hadron Therapy Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Hadron Therapy Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Hadron Therapy Value Market Share by Countries in 2017
Table Middle East & Africa Hadron Therapy Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Hadron Therapy Consumption Market Share by Type in 2017
Table Middle East & Africa Hadron Therapy Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Hadron Therapy Consumption Market Share by Application in 2017
Figure Egypt Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Egypt Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure South Africa Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure South Africa Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Israel Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Israel Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Turkey Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Turkey Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Hadron Therapy Value Growth 2013-2018 ($ Millions)
Table Hadron Therapy Distributors List
Table Hadron Therapy Customer List
Figure Global Hadron Therapy Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Hadron Therapy Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Hadron Therapy Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Hadron Therapy Consumption Market Forecast by Regions
Table Global Hadron Therapy Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Hadron Therapy Value Market Share Forecast by Regions
Figure Americas Hadron Therapy Consumption 2018-2023 (K Units)
Figure Americas Hadron Therapy Value 2018-2023 ($ Millions)
Figure APAC Hadron Therapy Consumption 2018-2023 (K Units)
Figure APAC Hadron Therapy Value 2018-2023 ($ Millions)
Figure Europe Hadron Therapy Consumption 2018-2023 (K Units)
Figure Europe Hadron Therapy Value 2018-2023 ($ Millions)
Figure Middle East & Africa Hadron Therapy Consumption 2018-2023 (K Units)
Figure Middle East & Africa Hadron Therapy Value 2018-2023 ($ Millions)
Figure United States Hadron Therapy Consumption 2018-2023 (K Units)
Figure United States Hadron Therapy Value 2018-2023 ($ Millions)
Figure Canada Hadron Therapy Consumption 2018-2023 (K Units)
Figure Canada Hadron Therapy Value 2018-2023 ($ Millions)
Figure Mexico Hadron Therapy Consumption 2018-2023 (K Units)
Figure Mexico Hadron Therapy Value 2018-2023 ($ Millions)
Figure Brazil Hadron Therapy Consumption 2018-2023 (K Units)
Figure Brazil Hadron Therapy Value 2018-2023 ($ Millions)
Figure China Hadron Therapy Consumption 2018-2023 (K Units)
Figure China Hadron Therapy Value 2018-2023 ($ Millions)
Figure Japan Hadron Therapy Consumption 2018-2023 (K Units)
Figure Japan Hadron Therapy Value 2018-2023 ($ Millions)
Figure Korea Hadron Therapy Consumption 2018-2023 (K Units)
Figure Korea Hadron Therapy Value 2018-2023 ($ Millions)
Figure Southeast Asia Hadron Therapy Consumption 2018-2023 (K Units)
Figure Southeast Asia Hadron Therapy Value 2018-2023 ($ Millions)
Figure India Hadron Therapy Consumption 2018-2023 (K Units)
Figure India Hadron Therapy Value 2018-2023 ($ Millions)
Figure Australia Hadron Therapy Consumption 2018-2023 (K Units)
Figure Australia Hadron Therapy Value 2018-2023 ($ Millions)
Figure Germany Hadron Therapy Consumption 2018-2023 (K Units)
Figure Germany Hadron Therapy Value 2018-2023 ($ Millions)
Figure France Hadron Therapy Consumption 2018-2023 (K Units)
Figure France Hadron Therapy Value 2018-2023 ($ Millions)
Figure UK Hadron Therapy Consumption 2018-2023 (K Units)
Figure UK Hadron Therapy Value 2018-2023 ($ Millions)
Figure Italy Hadron Therapy Consumption 2018-2023 (K Units)
Figure Italy Hadron Therapy Value 2018-2023 ($ Millions)
Figure Russia Hadron Therapy Consumption 2018-2023 (K Units)
Figure Russia Hadron Therapy Value 2018-2023 ($ Millions)
Figure Spain Hadron Therapy Consumption 2018-2023 (K Units)
Figure Spain Hadron Therapy Value 2018-2023 ($ Millions)
Figure Egypt Hadron Therapy Consumption 2018-2023 (K Units)
Figure Egypt Hadron Therapy Value 2018-2023 ($ Millions)
Figure South Africa Hadron Therapy Consumption 2018-2023 (K Units)
Figure South Africa Hadron Therapy Value 2018-2023 ($ Millions)
Figure Israel Hadron Therapy Consumption 2018-2023 (K Units)
Figure Israel Hadron Therapy Value 2018-2023 ($ Millions)
Figure Turkey Hadron Therapy Consumption 2018-2023 (K Units)
Figure Turkey Hadron Therapy Value 2018-2023 ($ Millions)
Figure GCC Countries Hadron Therapy Consumption 2018-2023 (K Units)
Figure GCC Countries Hadron Therapy Value 2018-2023 ($ Millions)
Table Global Hadron Therapy Consumption Forecast by Type (2018-2023) (K Units)
Table Global Hadron Therapy Consumption Market Share Forecast by Type (2018-2023)
Table Global Hadron Therapy Value Forecast by Type (2018-2023) ($ Millions)
Table Global Hadron Therapy Value Market Share Forecast by Type (2018-2023)
Table Global Hadron Therapy Consumption Forecast by Application (2018-2023) (K Units)
Table Global Hadron Therapy Consumption Market Share Forecast by Application (2018-2023)
Table Global Hadron Therapy Value Forecast by Application (2018-2023) ($ Millions)
Table Global Hadron Therapy Value Market Share Forecast by Application (2018-2023)
Table Koninklijke Philips N.V. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Koninklijke Philips N.V. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Koninklijke Philips N.V. Hadron Therapy Market Share (2016-2018)
Table Advanced Oncotherapy Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Advanced Oncotherapy Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Advanced Oncotherapy Hadron Therapy Market Share (2016-2018)
Table Varian Medical Systems, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Varian Medical Systems, Inc. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Varian Medical Systems, Inc. Hadron Therapy Market Share (2016-2018)
Table Optivus Proton Therapy, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Optivus Proton Therapy, Inc. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Optivus Proton Therapy, Inc. Hadron Therapy Market Share (2016-2018)
Table Hitachi, Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hitachi, Ltd. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hitachi, Ltd. Hadron Therapy Market Share (2016-2018)
Table Mevion Medical Systems Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mevion Medical Systems Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mevion Medical Systems Hadron Therapy Market Share (2016-2018)
Table ProTom International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ProTom International Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ProTom International Hadron Therapy Market Share (2016-2018)
Table Mitsubishi Electric Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Electric Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mitsubishi Electric Corporation Hadron Therapy Market Share (2016-2018)
Table Sumitomo Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sumitomo Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sumitomo Corporation Hadron Therapy Market Share (2016-2018)
Table ProNova Solutions, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ProNova Solutions, LLC Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ProNova Solutions, LLC Hadron Therapy Market Share (2016-2018)
Figure Picture of Hadron Therapy
Table Product Specifications of Hadron Therapy
Figure Hadron Therapy Report Years Considered
Figure Market Research Methodology
Figure Global Hadron Therapy Consumption Growth Rate 2013-2023 (K Units)
Figure Global Hadron Therapy Value Growth Rate 2013-2023 ($ Millions)
Table Hadron Therapy Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Electron Beam
Table Major Players of Electron Beam
Figure Product Picture of Proton Beam
Table Major Players of Proton Beam
Figure Product Picture of Neutron Beam
Table Major Players of Neutron Beam
Figure Product Picture of Carbon Ion Beam
Table Major Players of Carbon Ion Beam
Figure Product Picture of Alpha Particle Beam
Table Major Players of Alpha Particle Beam
Figure Product Picture of Beta Particle Beam
Table Major Players of Beta Particle Beam
Table Global Consumption Sales by Type (2013-2018)
Table Global Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure Global Hadron Therapy Consumption Market Share by Type (2013-2018)
Table Global Hadron Therapy Revenue by Type (2013-2018) ($ million)
Table Global Hadron Therapy Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Hadron Therapy Value Market Share by Type (2013-2018)
Table Global Hadron Therapy Sale Price by Type (2013-2018)
Figure Hadron Therapy Consumed in Pediatric Cancer
Figure Global Hadron Therapy Market: Pediatric Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Pediatric Cancer (2013-2018) ($ Millions)
Figure Global Pediatric Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Bone and Soft Tissue Cancer
Figure Global Hadron Therapy Market: Bone and Soft Tissue Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Bone and Soft Tissue Cancer (2013-2018) ($ Millions)
Figure Global Bone and Soft Tissue Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Prostate Cancer
Figure Global Hadron Therapy Market: Prostate Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Prostate Cancer (2013-2018) ($ Millions)
Figure Global Prostate Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Lung Cancer
Figure Global Hadron Therapy Market: Lung Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Lung Cancer (2013-2018) ($ Millions)
Figure Global Lung Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Liver Cancer
Figure Global Hadron Therapy Market: Liver Cancer (2013-2018) (K Units)
Figure Global Hadron Therapy Market: Liver Cancer (2013-2018) ($ Millions)
Figure Global Liver Cancer YoY Growth ($ Millions)
Figure Hadron Therapy Consumed in Eye Cancer
Figure Hadron Therapy Consumed in Head & Neck Cancer
Figure Hadron Therapy Consumed in Others Applications (Renal Cell Carcinoma, Cervical, Gastric, and Lymphoma)
Table Global Consumption Sales by Application (2013-2018)
Table Global Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure Global Hadron Therapy Consumption Market Share by Application (2013-2018)
Table Global Hadron Therapy Value by Application (2013-2018)
Table Global Hadron Therapy Value Market Share by Application (2013-2018)
Figure Global Hadron Therapy Value Market Share by Application (2013-2018)
Table Global Hadron Therapy Sale Price by Application (2013-2018)
Table Global Hadron Therapy Sales by Players (2016-2018) (K Units)
Table Global Hadron Therapy Sales Market Share by Players (2016-2018)
Figure Global Hadron Therapy Sales Market Share by Players in 2016
Figure Global Hadron Therapy Sales Market Share by Players in 2017
Table Global Hadron Therapy Revenue by Players (2016-2018) ($ Millions)
Table Global Hadron Therapy Revenue Market Share by Players (2016-2018)
Figure Global Hadron Therapy Revenue Market Share by Players in 2016
Figure Global Hadron Therapy Revenue Market Share by Players in 2017
Table Global Hadron Therapy Sale Price by Players (2016-2018)
Figure Global Hadron Therapy Sale Price by Players in 2017
Table Global Hadron Therapy Manufacturing Base Distribution and Sales Area by Players
Table Players Hadron Therapy Products Offered
Table Hadron Therapy Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Hadron Therapy Consumption by Regions 2013-2018 (K Units)
Table Global Hadron Therapy Consumption Market Share by Regions 2013-2018
Figure Global Hadron Therapy Consumption Market Share by Regions 2013-2018
Table Global Hadron Therapy Value by Regions 2013-2018 ($ Millions)
Table Global Hadron Therapy Value Market Share by Regions 2013-2018
Figure Global Hadron Therapy Value Market Share by Regions 2013-2018
Figure Americas Hadron Therapy Consumption 2013-2018 (K Units)
Figure Americas Hadron Therapy Value 2013-2018 ($ Millions)
Figure APAC Hadron Therapy Consumption 2013-2018 (K Units)
Figure APAC Hadron Therapy Value 2013-2018 ($ Millions)
Figure Europe Hadron Therapy Consumption 2013-2018 (K Units)
Figure Europe Hadron Therapy Value 2013-2018 ($ Millions)
Figure Middle East & Africa Hadron Therapy Consumption 2013-2018 (K Units)
Figure Middle East & Africa Hadron Therapy Value 2013-2018 ($ Millions)
Table Americas Hadron Therapy Consumption by Countries (2013-2018) (K Units)
Table Americas Hadron Therapy Consumption Market Share by Countries (2013-2018)
Figure Americas Hadron Therapy Consumption Market Share by Countries in 2017
Table Americas Hadron Therapy Value by Countries (2013-2018) ($ Millions)
Table Americas Hadron Therapy Value Market Share by Countries (2013-2018)
Figure Americas Hadron Therapy Value Market Share by Countries in 2017
Table Americas Hadron Therapy Consumption by Type (2013-2018) (K Units)
Table Americas Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure Americas Hadron Therapy Consumption Market Share by Type in 2017
Table Americas Hadron Therapy Consumption by Application (2013-2018) (K Units)
Table Americas Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure Americas Hadron Therapy Consumption Market Share by Application in 2017
Figure United States Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure United States Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Canada Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Canada Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Mexico Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Mexico Hadron Therapy Value Growth 2013-2018 ($ Millions)
Table APAC Hadron Therapy Consumption by Countries (2013-2018) (K Units)
Table APAC Hadron Therapy Consumption Market Share by Countries (2013-2018)
Figure APAC Hadron Therapy Consumption Market Share by Countries in 2017
Table APAC Hadron Therapy Value by Countries (2013-2018) ($ Millions)
Table APAC Hadron Therapy Value Market Share by Countries (2013-2018)
Figure APAC Hadron Therapy Value Market Share by Countries in 2017
Table APAC Hadron Therapy Consumption by Type (2013-2018) (K Units)
Table APAC Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure APAC Hadron Therapy Consumption Market Share by Type in 2017
Table APAC Hadron Therapy Consumption by Application (2013-2018) (K Units)
Table APAC Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure APAC Hadron Therapy Consumption Market Share by Application in 2017
Figure China Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure China Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Japan Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Japan Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Korea Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Korea Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure India Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure India Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Australia Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Australia Hadron Therapy Value Growth 2013-2018 ($ Millions)
Table Europe Hadron Therapy Consumption by Countries (2013-2018) (K Units)
Table Europe Hadron Therapy Consumption Market Share by Countries (2013-2018)
Figure Europe Hadron Therapy Consumption Market Share by Countries in 2017
Table Europe Hadron Therapy Value by Countries (2013-2018) ($ Millions)
Table Europe Hadron Therapy Value Market Share by Countries (2013-2018)
Figure Europe Hadron Therapy Value Market Share by Countries in 2017
Table Europe Hadron Therapy Consumption by Type (2013-2018) (K Units)
Table Europe Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure Europe Hadron Therapy Consumption Market Share by Type in 2017
Table Europe Hadron Therapy Consumption by Application (2013-2018) (K Units)
Table Europe Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure Europe Hadron Therapy Consumption Market Share by Application in 2017
Figure Germany Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Germany Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure France Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure France Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure UK Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure UK Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Italy Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Italy Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Russia Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Russia Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Spain Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Spain Hadron Therapy Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Hadron Therapy Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Hadron Therapy Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Hadron Therapy Consumption Market Share by Countries in 2017
Table Middle East & Africa Hadron Therapy Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Hadron Therapy Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Hadron Therapy Value Market Share by Countries in 2017
Table Middle East & Africa Hadron Therapy Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Hadron Therapy Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Hadron Therapy Consumption Market Share by Type in 2017
Table Middle East & Africa Hadron Therapy Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Hadron Therapy Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Hadron Therapy Consumption Market Share by Application in 2017
Figure Egypt Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Egypt Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure South Africa Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure South Africa Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Israel Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Israel Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure Turkey Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure Turkey Hadron Therapy Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Hadron Therapy Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Hadron Therapy Value Growth 2013-2018 ($ Millions)
Table Hadron Therapy Distributors List
Table Hadron Therapy Customer List
Figure Global Hadron Therapy Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Hadron Therapy Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Hadron Therapy Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Hadron Therapy Consumption Market Forecast by Regions
Table Global Hadron Therapy Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Hadron Therapy Value Market Share Forecast by Regions
Figure Americas Hadron Therapy Consumption 2018-2023 (K Units)
Figure Americas Hadron Therapy Value 2018-2023 ($ Millions)
Figure APAC Hadron Therapy Consumption 2018-2023 (K Units)
Figure APAC Hadron Therapy Value 2018-2023 ($ Millions)
Figure Europe Hadron Therapy Consumption 2018-2023 (K Units)
Figure Europe Hadron Therapy Value 2018-2023 ($ Millions)
Figure Middle East & Africa Hadron Therapy Consumption 2018-2023 (K Units)
Figure Middle East & Africa Hadron Therapy Value 2018-2023 ($ Millions)
Figure United States Hadron Therapy Consumption 2018-2023 (K Units)
Figure United States Hadron Therapy Value 2018-2023 ($ Millions)
Figure Canada Hadron Therapy Consumption 2018-2023 (K Units)
Figure Canada Hadron Therapy Value 2018-2023 ($ Millions)
Figure Mexico Hadron Therapy Consumption 2018-2023 (K Units)
Figure Mexico Hadron Therapy Value 2018-2023 ($ Millions)
Figure Brazil Hadron Therapy Consumption 2018-2023 (K Units)
Figure Brazil Hadron Therapy Value 2018-2023 ($ Millions)
Figure China Hadron Therapy Consumption 2018-2023 (K Units)
Figure China Hadron Therapy Value 2018-2023 ($ Millions)
Figure Japan Hadron Therapy Consumption 2018-2023 (K Units)
Figure Japan Hadron Therapy Value 2018-2023 ($ Millions)
Figure Korea Hadron Therapy Consumption 2018-2023 (K Units)
Figure Korea Hadron Therapy Value 2018-2023 ($ Millions)
Figure Southeast Asia Hadron Therapy Consumption 2018-2023 (K Units)
Figure Southeast Asia Hadron Therapy Value 2018-2023 ($ Millions)
Figure India Hadron Therapy Consumption 2018-2023 (K Units)
Figure India Hadron Therapy Value 2018-2023 ($ Millions)
Figure Australia Hadron Therapy Consumption 2018-2023 (K Units)
Figure Australia Hadron Therapy Value 2018-2023 ($ Millions)
Figure Germany Hadron Therapy Consumption 2018-2023 (K Units)
Figure Germany Hadron Therapy Value 2018-2023 ($ Millions)
Figure France Hadron Therapy Consumption 2018-2023 (K Units)
Figure France Hadron Therapy Value 2018-2023 ($ Millions)
Figure UK Hadron Therapy Consumption 2018-2023 (K Units)
Figure UK Hadron Therapy Value 2018-2023 ($ Millions)
Figure Italy Hadron Therapy Consumption 2018-2023 (K Units)
Figure Italy Hadron Therapy Value 2018-2023 ($ Millions)
Figure Russia Hadron Therapy Consumption 2018-2023 (K Units)
Figure Russia Hadron Therapy Value 2018-2023 ($ Millions)
Figure Spain Hadron Therapy Consumption 2018-2023 (K Units)
Figure Spain Hadron Therapy Value 2018-2023 ($ Millions)
Figure Egypt Hadron Therapy Consumption 2018-2023 (K Units)
Figure Egypt Hadron Therapy Value 2018-2023 ($ Millions)
Figure South Africa Hadron Therapy Consumption 2018-2023 (K Units)
Figure South Africa Hadron Therapy Value 2018-2023 ($ Millions)
Figure Israel Hadron Therapy Consumption 2018-2023 (K Units)
Figure Israel Hadron Therapy Value 2018-2023 ($ Millions)
Figure Turkey Hadron Therapy Consumption 2018-2023 (K Units)
Figure Turkey Hadron Therapy Value 2018-2023 ($ Millions)
Figure GCC Countries Hadron Therapy Consumption 2018-2023 (K Units)
Figure GCC Countries Hadron Therapy Value 2018-2023 ($ Millions)
Table Global Hadron Therapy Consumption Forecast by Type (2018-2023) (K Units)
Table Global Hadron Therapy Consumption Market Share Forecast by Type (2018-2023)
Table Global Hadron Therapy Value Forecast by Type (2018-2023) ($ Millions)
Table Global Hadron Therapy Value Market Share Forecast by Type (2018-2023)
Table Global Hadron Therapy Consumption Forecast by Application (2018-2023) (K Units)
Table Global Hadron Therapy Consumption Market Share Forecast by Application (2018-2023)
Table Global Hadron Therapy Value Forecast by Application (2018-2023) ($ Millions)
Table Global Hadron Therapy Value Market Share Forecast by Application (2018-2023)
Table Koninklijke Philips N.V. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Koninklijke Philips N.V. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Koninklijke Philips N.V. Hadron Therapy Market Share (2016-2018)
Table Advanced Oncotherapy Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Advanced Oncotherapy Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Advanced Oncotherapy Hadron Therapy Market Share (2016-2018)
Table Varian Medical Systems, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Varian Medical Systems, Inc. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Varian Medical Systems, Inc. Hadron Therapy Market Share (2016-2018)
Table Optivus Proton Therapy, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Optivus Proton Therapy, Inc. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Optivus Proton Therapy, Inc. Hadron Therapy Market Share (2016-2018)
Table Hitachi, Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hitachi, Ltd. Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hitachi, Ltd. Hadron Therapy Market Share (2016-2018)
Table Mevion Medical Systems Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mevion Medical Systems Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mevion Medical Systems Hadron Therapy Market Share (2016-2018)
Table ProTom International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ProTom International Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ProTom International Hadron Therapy Market Share (2016-2018)
Table Mitsubishi Electric Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mitsubishi Electric Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mitsubishi Electric Corporation Hadron Therapy Market Share (2016-2018)
Table Sumitomo Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sumitomo Corporation Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sumitomo Corporation Hadron Therapy Market Share (2016-2018)
Table ProNova Solutions, LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ProNova Solutions, LLC Hadron Therapy Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ProNova Solutions, LLC Hadron Therapy Market Share (2016-2018)
